Financial Instruments - Schedule of Available-for-Sale Financial Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Cash equivalents:
Amortized Cost	$ 252,524	$ 182,571
Marketable securities:
Amortized Cost	35,275	229,488
Unrealized Gains	42	140
Unrealized Losses	(89)	(867)
Fair Value	35,228	228,761
Corporate securities
Marketable securities:
Amortized Cost	31,098	199,084
Unrealized Gains	36	115
Unrealized Losses	(89)	(819)
Fair Value	31,045	198,380
U.S. treasury and agency securities
Marketable securities:
Amortized Cost	4,177	30,404
Unrealized Gains	6	25
Unrealized Losses	0	(48)
Fair Value	$ 4,183	30,381
Cash equivalents
Cash equivalents:
Amortized Cost		1,213
Unrealized Gain		0
Unrealized Losses		(1)
Fair Value		1,212
Corporate securities
Cash equivalents:
Amortized Cost		1,213
Unrealized Gain		0
Unrealized Losses		(1)
Fair Value		$ 1,212